$MAXHEALTH e Shares Slide 6%, Among Top Nifty 50 Decliners Post Q4 Results

Shares of $MAXHEALTH lthcare Institute tumbled nearly 6 per cent in early Thursday trade after the healthcare major posted a moderate increase in fourth-quarter earnings. Investor sentiment remained subdued amid concerns over margin pressure, despite stable operational performance and ongoing expansion initiatives. The stock slipped to an intraday low of ₹1,028.20 on the NSE, emerging as one of the biggest laggards in the Nifty 50 index. The company posted a consolidated profit after tax of ₹387 crore for the quarter ended March 31, 2026, registering a 3 per cent year-on-year rise from ₹376 crore reported in the same quarter last year. Meanwhile, gross revenue climbed 10 per cent year-on-year to ₹2,664 crore during the period. Operational performance remained resilient, with bed occupancy maintained at 75 per cent, while occupied bed days increased 8 per cent year-on-year. Average revenue per occupied bed (ARPOB) improved marginally to ₹77,900 in Q4 FY26, compared with ₹77,100 in the corresponding quarter of the previous fiscal. For the full financial year FY26, the hospital network reported gross revenue of ₹10,538 crore. Profit after tax, excluding exceptional items, rose 22 per cent year-on-year to ₹1,631 crore, compared with ₹1,336 crore in FY25. The board of directors recommended a final dividend of ₹2 per equity share for FY26. Additionally, the company approved a capital expenditure plan of ₹1,400 crore to develop a 712-bed greenfield hospital at Shaheed Path in Lucknow. Spread over five acres, the proposed facility is expected to become operational in FY30 and will mark the company’s second hospital in the city. Max Healthcare Shares Slide 6%, Among Top Nifty 50 Decliners Post Q4 Results